Fluconazole binding and sterol demethylation in three CYP51 isoforms indicate differences in active site topology

This publication has 23 references indexed in Scilit:

• Conservation and cloning of CYP51: a sterol 14α-demethylase from Mycobacterium smegmatis
  Biochemical and Biophysical Research Communications, 2003
• A Novel Sterol 14α-Demethylase/Ferredoxin Fusion Protein (MCCYP51FX) from Methylococcus capsulatusRepresents a New Class of the Cytochrome P450 Superfamily
  Journal of Biological Chemistry, 2002
• Characterization and catalytic properties of the sterol 14α-demethylase from Mycobacterium tuberculosis
  Proceedings of the National Academy of Sciences, 1999
• Active efflux by multidrug transporters as one of the strategies to evade chemotherapy and novel practical implications of yeast pleiotropic drug resistance
  Pharmacology & Therapeutics, 1997
• The Mutation T315A in Candida albicans Sterol 14α-Demethylase Causes Reduced Enzyme Activity and Fluconazole Resistance through Reduced Affinity
  Journal of Biological Chemistry, 1997
• Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters
  Antimicrobial Agents and Chemotherapy, 1995
• Selective Inhibition of Mammalian Lanosterol 14.alpha.-Demethylase by RS-21607 in vitro and in vivo
  Biochemistry, 1994
• Ro 09-1470 is a selective inhibitor of P-450 lanosterol C-14 demethylase of fungi
  Antimicrobial Agents and Chemotherapy, 1993
• Sterol 14α-demethylase and its inhibition: structural considerations on interaction of azole antifungal agents with lanosterol 14α-demethylase (P-45014DM) of yeast
  Biochemical Society Transactions, 1991
• Defective sterol C5-6 desaturation and azole resistance: A new hypothesis for the mode of action of azole antifungals
  Biochemical and Biophysical Research Communications, 1989